Portfolio company
Microvessel cancer diagnostic
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops high-definition ultrasound imaging software to help clinicians non-invasively differentiate between malignant and benign tumours by visualising small blood vessels.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PCaVision
This company develops artificial intelligence software that analyses ultrasound recordings to assist urologists with prostate cancer diagnosis and biopsy planning for clinical patients.
Angiogenesis Analytics
This company develops AI-powered software that analyses ultrasound images to help urologists detect and locate prostate cancer tumours.
Oncoustics
This company develops AI-powered software that analyses raw ultrasound signals for non-invasive liver disease diagnostics and tissue characterisation for clinics and pharmaceutical partners.
Soundsafe Care
This company develops a robotic high-intensity focused ultrasound system for the non-invasive treatment of tumours in human and veterinary oncology patients.
Medo
This company develops artificial intelligence software for ultrasound imaging to assist healthcare professionals in diagnosing medical conditions.
ThinkSono
The company develops ultrasound guidance software that enables non-specialist healthcare professionals to detect deep vein thrombosis at the point of care.
Deep Light Vision
This company develops quantum-enabled ultrasound optical tomography imaging devices for clinicians to diagnose breast cancer and monitor neonatal health.
Medical Imaging
This company develops artificial intelligence-powered medical imaging devices and reconstruction software to enhance diagnostic scan quality and efficiency for clinicians and healthcare providers.
